Pharmaceutical Reports
Facing patent expirations, pricing pressures, and R&D productivity challenges, pharma companies are relying on market research and consulting services to identify growth opportunities, demonstrate value, and bring innovative therapies to market. This guide provides insights into the pharma consulting landscape.
Atopic Dermatitis Market
Atopic Dermatitis Market, By Disease Type (Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Neurodermatitis, Nummular Dermatitis), By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Biologics, Others (Complementary and Alternative Therapies), Immunosuppressants, Others (Antihistamines, Emollients), By Route of Administration (Oral, Parenteral, Topical Name of Segment 4 (By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Direct Tenders, Mail Order), By Drug Class (Corticosteroids, Calcineurin Inhibitors, Immunomodulators, Interleukin Inhibitors, JAK Inhibitors), By End User (Hospitals, Specialty Clinics, Homecare Settings, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Sanofi, Regeneron Pharmaceuticals, Pfizer, AbbVie, Eli Lilly and Company, Novartis
Epilepsy Market
Epilepsy Market, By Product Type (Anti-seizure Medications, Vagus Nerve Stimulators, Deep Brain Stimulators, Laser Ablation Devices, Ketogenic Diet Therapies, Dietary Supplements, Others), By Seizure Type (Focal Seizures, Generalized Seizures, Myoclonic Seizures, Absence Seizures, Tonic-Clonic Seizures, Atonic Seizures, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings, Research Institutes, Academic Institutions, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Mail-Order Pharmacies, Specialty Pharmacies, Direct-to-Consumer, Others), By Application (Epilepsy, Lennox-Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex, Infantile Spasms, Febrile Seizures, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: UCB S.A., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson
Diabetic Kidney Disease (DKD) Market
Diabetic Kidney Disease (DKD) Market, By Therapy Type (Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Agonists, Dual SGLT1/SGLT2 Inhibitors, Mineralocorticoid Receptor Antagonists, Others), By Drug Class (Early-Stage DKD, Moderate DKD, Advanced DKD, End-Stage Renal Disease (ESRD)), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Dialysis Centers, Homecare Settings), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Novo Nordisk A/S, Bayer AG, AstraZeneca plc, Boehringer Ingelheim International GmbH, Eli Lilly
Soft Tissue Sarcoma Market
Soft Tissue Sarcoma Market, By Product Type (Chemotherapeutic Agents, Targeted Therapies, Immunotherapies, Radiation Therapy, Surgical Devices, Diagnostic Imaging Equipment, Others), By End-User (Hospitals, Oncology Centers, Ambulatory Surgical Centers, Research Institutes, Home Care Settings, Others), By Soft Tissue Sarcoma Type (Liposarcoma, Leiomyosarcoma, Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor, Rhabdomyosarcoma, Others), By Treatment Modality (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Combination Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct-to-Consumer, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Novartis AG, Pfizer Inc., Bayer AG, Merck & Co., Inc., GlaxoSmithKline plc, Eli Lilly and Company
Ulcerative Colitis Market
Ulcerative Colitis Market, By Product Type (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Janus Kinase (JAK) Inhibitors, Others (Antibiotics, Antidiarrheals, Laxatives)), By Route of Administration (Oral, Topical, Parenteral, Others), By Disease Type (Mild Ulcerative Colitis, Moderate Ulcerative Colitis, Severe Ulcerative Colitis), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others (Retail Pharmacies, Online Pharmacies)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AbbVie Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson
Vernal Keratoconjunctivitis Market
Vernal Keratoconjunctivitis Market, By Disease Type (Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC), Giant Papillary Conjunctivitis (GPC), Phlyctenular Keratoconjunctivitis, Others), By Treatment Type (Antihistamines, Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Antibiotics, Artificial Tears, Others), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Novartis AG, Bausch Health Companies Inc., Allergan plc, Santen Pharmaceutical Co., Ltd., Akorn, Inc.
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market, By Drug Class (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Vildagliptin, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Disease Indication (Type 2 Diabetes Mellitus, Others), By Patient Demographics (Geriatric Population, Adults, Pediatrics), By End-User (Hospitals, Homecare, Specialty Clinics, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Novartis AG, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Cutaneous T-Cell Lymphoma (CTCL) Market
Cutaneous T-Cell Lymphoma (CTCL) Market, By Type (Prefilled Syringe, Injectable, Lyophilized), By Hematopoietic Stem Cell Transplantation Type (Autologous, Allogeneic), By End-user (Hospitals, Specialty Clinics, Stem Cell Banks, Others), By Combination Therapy (Plerixafor + GCSF, Plerixafor + Chemo + GCSF, Others), By Application (Non-Hodgkin’s Lymphoma, Multiple Myeloma, Hodgkin’s Lymphoma, Acute Myeloid Leukemia, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Genzyme Corporation, Sanofi S.A, Cadila Healthcare, Mylan N.V., IDsA Generics, Cipla Ltd.
Connective Tissue Growth Factor (CTGF) Inhibitors Market
Connective Tissue Growth Factor (CTGF) Inhibitors Market, By Product Type (Monoclonal Antibodies, Small Molecule Inhibitors, Antisense Oligonucleotides, Others (Gene Therapies, RNAi-based therapies)), By Therapeutic Area (Idiopathic Pulmonary Fibrosis (IPF), Diabetic Kidney Disease, Liver Fibrosis, Systemic Sclerosis, Cardiac Fibrosis, Others (Skin Fibrosis, Macular Degeneration)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: FibroGen, Inc., Gilead Sciences, Inc., Biogen Inc., Merck & Co., Inc., Roche Holding AG
Cough In Idiopathic Pulmonary Fibrosis (IPF) Market
Cough in Idiopathic Pulmonary Fibrosis (IPF) Market, By Drug Class (Anti-fibrotic agents, Immunosuppressants, Corticosteroids, Antioxidants, Others (Mucolytics, Bronchodilators)), By Route of Administration (Oral, Inhalation, Intravenous, Others (Subcutaneous, Intramuscular)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Specialty Pharmacies, Mail Order Pharmacies)), By Disease Subtype (Idiopathic Pulmonary Fibrosis (IPF), Non-IPF Interstitial Lung Diseases (ILDs), Acute Interstitial Pneumonitis, Chronic Hypersensitivity Pneumonitis, Others (Cryptogenic Organizing Pneumonia, Sarcoidosis)), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings, Others (Research Institutes, Academic Institutions)), By Mechanism of Action (Tyrosine Kinase Inhibitors, Antioxidants, Anti-inflammatory Agents, Immunosuppressants, Others (Mucolytics, Bronchodilators)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Roche, Boehringer Ingelheim, Genentech, Fibrogen, Prometic Life Sciences, Galapagos